Jump to main content

博士論文

Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts.

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Available in National Diet Library

Find on the publisher's website

国立国会図書館デジタルコレクション

Digital data available

Check on the publisher's website

Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts.

Persistent ID (NDL)
info:ndljp/pid/11679726
Material type
博士論文
Author
水野, 雅司
Publisher
-
Publication date
2018-03-31
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
札幌医科大学,博士（医学）
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Search by Bookstore

Search by Bookstore

Read this material in an accessible format.

View materials in accessible formats for people with print disabilities (1Type)

Search by Bookstore

Read in Disability Resources

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Title
Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts.
Author/Editor
水野, 雅司
Author Heading
水野, 雅司
Publication Date
2018-03-31
Publication Date (W3CDTF)
2018-03-31
Alternative Title
エンパグリフロジンは糖尿病心におけるミトコンドリアのサイズと数を正常化し、心筋梗塞後のミトコンドリアサイズ縮小を防ぐ
Degree grantor/type
札幌医科大学
Date Granted
2018-03-31
Date Granted (W3CDTF)
2018-03-31